MORBIDITY AND MORTALITY IN ADULT FONTAN PATIENTS AFTER HEART OR COMBINED HEART LIVER TRANSPLANT: A REPORT FROM THE FOSTER STUDY

Matthew J. Lewis,Leigh Reardon,Jamil A. Aboulhosn,Christiane Haeffele,Sharon Chen,Yuli Y. Kim,Wendy Book,Fred H. Rodriguez,Anne Marie Valente,Matthew Carazo,Eric Krieger,Jilian Angiulo,Alexander Egbe,Ari M. Cedars,Jong Ko,Roni Jacobson,Michael Earing,Peter Ermis,Chris Broda,Jonathan W. Cramer,Natalia Nugaeva,Heather Joan Ross,Richard A. Krasuski,Marlon Rosenbaum

MORBIDITY AND MORTALITY IN ADULT FONTAN PATIENTS AFTER HEART OR COMBINED HEART LIVER TRANSPLANT: A REPORT FROM THE FOSTER STUDY

2020

We examined a retrospective, multicenter cohort of adult Fontan patients referred for heart transplant (HT) to assess the impact of comorbidities and combined heart-liver transplant (CHLT) on mortality. All patients at participating institutions with a history of a Fontan-type palliation referred

Keywords:

Diabetes mellitus
Pediatrics
Medicine
Cardiology
Internal medicine
Cohort

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations